This year till Q3 eight major pharma giants were very active in terms of mergers and acquisition and in licensing deals in Biotechnology products they include GSK, Merck, Johnson and Johnson, Sanofi Aventis, Pfizer, Novartis, Abbott and BMS. Bristol Myers Squibb though had sufficient liquid cash reserves with itself but it did not go for any major billion dollar deal.....On the other hand it has divested some of its drug licences in middle east and today it announced that it is going to sell its stake in Mead Johnson Nutrition company which is into infant food (Last year revenue from this segment- $2.2 Million), BMS is now keen in moving into biotechnology domain with back up fund of around 4 to 6 Billion dollar. Now I am keeping my fingers crossed and waiting for the next big Billion dollar deal to happen by next Quarter :)….may be next billion dollar deal by BMS :)
No comments:
Post a Comment